Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Billich

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2002
Thymosin alpha1. SciClone PharmaceuticalsAndreas Billich
Idrugs : the Investigational Drugs Journal|December 26, 2006
Drug evaluation: apilimod, an oral IL-12/IL-23 inhibitor for the treatment of autoimmune diseases and common variable immunodeficiencyAndreas Billich
Current Opinion in Investigational Drugs (London, England : 2000)|March 27, 2004
AIDSVAX VaxGenAndreas Billich
Current Opinion in Investigational Drugs (London, England : 2000)|April 3, 2003
S-1360 Shionogi-GlaxoSmithKlineAndreas Billich
Current Opinion in Investigational Drugs (London, England : 2000)|April 3, 2003
HPV vaccine MedImmune/GlaxoSmithKlineAndreas Billich
Analytical Biochemistry|February 11, 2004
Fluorescence-based assay of sphingosine kinasesAndreas Billich, Peter Ettmayer
Medicinal Research Reviews|June 2, 2004
Steroid sulfatase inhibitorsPeter Nussbaumer, Andreas Billich
Current Medicinal Chemistry. Anti-Cancer Agents|September 24, 2005
Steroid sulfatase inhibitors: their potential in the therapy of breast cancerPeter Nussbaumer, Andreas Billich
Sub-Cellular Biochemistry|August 30, 2008
Sphingolipid metabolizing enzymes as novel therapeutic targetsAndreas Billich, Thomas Baumruker
Bioorganic & Medicinal Chemistry Letters|September 3, 2004
Estrone formate: a novel type of irreversible inhibitor of human steroid sulfataseErwin P Schreiner, Andreas Billich
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2002
Thymosin alpha1. SciClone PharmaceuticalsAndreas Billich
Idrugs : the Investigational Drugs Journal|December 26, 2006
Drug evaluation: apilimod, an oral IL-12/IL-23 inhibitor for the treatment of autoimmune diseases and common variable immunodeficiencyAndreas Billich
Current Opinion in Investigational Drugs (London, England : 2000)|March 27, 2004
AIDSVAX VaxGenAndreas Billich
Current Opinion in Investigational Drugs (London, England : 2000)|April 3, 2003
S-1360 Shionogi-GlaxoSmithKlineAndreas Billich
Current Opinion in Investigational Drugs (London, England : 2000)|April 3, 2003
HPV vaccine MedImmune/GlaxoSmithKlineAndreas Billich
Analytical Biochemistry|February 11, 2004
Fluorescence-based assay of sphingosine kinasesAndreas Billich, Peter Ettmayer
Medicinal Research Reviews|June 2, 2004
Steroid sulfatase inhibitorsPeter Nussbaumer, Andreas Billich
Current Medicinal Chemistry. Anti-Cancer Agents|September 24, 2005
Steroid sulfatase inhibitors: their potential in the therapy of breast cancerPeter Nussbaumer, Andreas Billich
Sub-Cellular Biochemistry|August 30, 2008
Sphingolipid metabolizing enzymes as novel therapeutic targetsAndreas Billich, Thomas Baumruker
Bioorganic & Medicinal Chemistry Letters|September 3, 2004
Estrone formate: a novel type of irreversible inhibitor of human steroid sulfataseErwin P Schreiner, Andreas Billich
Pageof 8